Phase II Study of Concurrent Continuous Temozolomide (TMZ) and Tamoxifen (TMX) for Recurrent Malignant Astrocytic Gliomas

被引：0
|
作者：
Alexander M. Spence
Richard A. Peterson
Jeffrey D. Scharnhorst
Daniel L. Silbergeld
Robert C. Rostomily
机构：
[1] University of Washington,Department of Neurology, 356465
[2] University of Washington School of Medicine,Departments of Neurology and Neurological Surgery
来源：
Journal of Neuro-Oncology | 2004年 / 70卷
关键词：
anaplastic astrocytoma; glioblastoma multiforme; phase II; Tamoxifen; Temozolomide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose and background: The aim of this study was to assess the frequency of response and toxicity in adults with recurrent anaplastic astrocytoma (AA) or glioblastoma multiforme (GM) treated with concurrent continuous TMZ and TMX.
引用
收藏
页码：91 / 95
页数：4
相关论文
共 50 条
  • [1] Phase II study of concurrent continuous Temozolomide (TMZ) and Tamoxifen (TMX) for recurrent malignant astrocytic gliomas
    Spence, AM
    Peterson, RA
    Scharnhorst, JD
    Silbergeld, DL
    Rostomily, RC
    JOURNAL OF NEURO-ONCOLOGY, 2004, 70 (01) : 91 - 95
  • [2] A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
    Odia, Yazmin
    Kreisl, Teri N.
    Aregawi, Dawit
    Innis, Ellen K.
    Fine, Howard A.
    JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (01) : 191 - 195
  • [3] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Peters, Katherine B.
    Lipp, Eric S.
    Miller, Elizabeth
    Herndon, James E., II
    McSherry, Frances
    Desjardins, Annick
    Reardon, David A.
    Friedman, Henry S.
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (02) : 349 - 356
  • [4] A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas
    Yazmín Odia
    Teri N. Kreisl
    Dawit Aregawi
    Ellen K. Innis
    Howard A. Fine
    Journal of Neuro-Oncology, 2015, 125 : 191 - 195
  • [5] Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas
    Katherine B. Peters
    Eric S. Lipp
    Elizabeth Miller
    James E. Herndon
    Frances McSherry
    Annick Desjardins
    David A. Reardon
    Henry S. Friedman
    Journal of Neuro-Oncology, 2018, 137 : 349 - 356
  • [6] Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas
    Blakeley, Jaishri O.
    Grossman, Stuart A.
    Mikkelsen, Tom
    Rosenfeld, Myrna R.
    Peereboom, David
    Nabors, L. Burt
    Chi, Andrew S.
    Emmons, Gary
    Ribas, Ignacio Garcia
    Supko, Jeffrey G.
    Desideri, Serena
    Ye, Xiaobu
    JOURNAL OF NEURO-ONCOLOGY, 2015, 125 (01) : 123 - 131
  • [7] Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma
    Omuro, Antonio
    Chan, Timothy A.
    Abrey, Lauren E.
    Khasraw, Mustafa
    Reiner, Anne S.
    Kaley, Thomas J.
    DeAngelis, Lisa M.
    Lassman, Andrew B.
    Nolan, Craig P.
    Gavrilovic, Igor T.
    Hormigo, Adilia
    Salvant, Cynthia
    Heguy, Adriana
    Kaufman, Andrew
    Huse, Jason T.
    Panageas, Katherine S.
    Hottinger, Andreas F.
    Mellinghoff, Ingo
    NEURO-ONCOLOGY, 2013, 15 (02) : 242 - 250
  • [8] Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas
    Balmaceda, Casilda
    Peereboom, David
    Pannullo, Susan
    Cheung, Ying Kuen K.
    Fisher, Paul G.
    Alavi, Jane
    Sisti, Michael
    Chen, Johnson
    Fine, Robert L.
    CANCER, 2008, 112 (05) : 1139 - 1146
  • [9] Phase I/II Study of Temozolomide Plus Nimustine Chemotherapy for Recurrent Malignant Gliomas: Kyoto Neuro-oncology Group
    Aoki, Tomokazu
    Arakawa, Yoshiki
    Ueba, Tetsuya
    Oda, Masashi
    Nishida, Namiko
    Akiyama, Yukinori
    Tsukahara, Tetsuya
    Iwasaki, Koichi
    Mikuni, Nobuhiro
    Miyamoto, Susumu
    NEUROLOGIA MEDICO-CHIRURGICA, 2017, 57 (01) : 17 - 27
  • [10] Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas
    Minniti, Giuseppe
    Scaringi, Claudia
    De Sanctis, Vitaliana
    Lanzetta, Gaetano
    Falco, Teresa
    Di Stefano, Domenica
    Esposito, Vincenzo
    Enrici, Riccardo Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (02) : 187 - 194
12345